Steritas’ Post

The current standard treatment around the world for #IgG4RD is glucocorticoids. But is the role of steroids in treating this disease outsized? 🤔 Hear from John Stone, MD MPH and Wen Zhang, MD PhD their thoughts on the #InflammatoryDisease and updates on trials for new steroid-sparing alternatives. Register here: https://hubs.li/Q025MFg90 #SteroidToxicity #Webinar #Rheumatology #SteritasGTI #Vasculitis

The current standard treatment around the world for #IgG4RD is glucocorticoids. But is the role of steroids in treating this disease outsized? 🤔 Hear from John Stone, MD MPH and Wen Zhang, MD PhD their thoughts on the #InflammatoryDisease and updates on trials for new steroid-sparing alternatives. Register here: https://hubs.li/Q025MD1y0 #SteroidToxicity #Webinar #Rheumatology #SteritasGTI #Vasculitis

🙌 I am pleased to share that the interesting special issue "Updates on Interstitial Lung Disease" calls for excellent submissions. https://lnkd.in/gd63A-NF Journal of Clinical Medicine (JCM) MDPI #Interstitial Lung

Mesothelioma trials are pivotal in advancing medical research and finding new therapies for this challenging disease. These trials are structured, multi-phase processes that adhere to strict protocols to ensure the safety and efficacy of potential treatments. Learn more about how mesothelioma trials can be beneficial to understanding mesothelioma and to help those fighting the disease. https://buff.ly/46ubZej #shraderlaw #mesothelioma #trialattorneys #mesotheliomalawfirms #asbestos

The Center for Disease Control has stated a syphilis epidemic is occurring in the United States, with sustained increases in primary and secondary syphilis from 5,979 cases reported in 2000 to 133,945 cases reported in 2020, a 2,140% increase¹. Laboratories have a critical role in the public health response to the syphilis epidemic. The responsibility of the laboratory is to test specimens and report results in a timely manner, allowing clinicians to efficiently make clinical diagnoses for patient management¹. Link to DTPM STI Test Kit: https://ow.ly/nWqN50QAgXU For Research Use Only. Not for use in diagnostic procedures. Link to STI Blog: https://ow.ly/Lf1X50QAgXT References 1.https://ow.ly/n6X850QAgXV

#DidYouKnow that 300 million people worldwide have a diagnosed rare and undertreated disease? Highly personalized therapies play an integral role in ongoing work to find effective, breakthrough treatments, with the majority of ATMPs currently developed targeting rare conditions. On #RareDiseaseDay, we want to shed a light on the journeys of those affected, and highlight the important advancements happening every day in patient-centered medicine.  #LightUpForRare

🔔 We are glad to share the following publication in the Journal of Clinical Medicine (JCM) MDPI: 📝 COVID-19 versus Other Disease Etiologies as the Cause of ARDS in Patients Necessitating Venovenous Extracorporeal Membrane Oxygenation—A Comparison of Patients’ Data during the Three Years of the COVID-19 Pandemic ✨https://lnkd.in/gg3GNv2Y 💥 Article Views: 819

Happy Rheumatoid Awareness Day! 💙 Rheumatoid disease is an autoimmune condition. The body believes the linings of the joints are foreign tissue, which causes the body to attack and damage the joints. This results in inflammation and pain, with arthritis being a major symptom of the #Rheumatoid disease. This disease affects more than a million Americans, most of them being women. #RheumatoidAwareness Day was created in 2013 to help raise awareness for the disease. Research has shown that a lack of public education and awareness, leads to a delay in seeking medical advice which can result in inadequate treatment. Click here https://bit.ly/3w5zQEY to check out our currently open Rheumatoid clinical trials!

Implementing a clinical intelligence solution requires collaboration among pharmaceutical companies, contract research organizations (CROs), technology providers, and regulatory bodies. By harnessing the power of data and artificial intelligence, clinical trials can become more efficient, cost-effective, and successful in bringing new therapies to market. This IBD analysis is just one way that Anju Software's TA Scan solution can help make data driven decisions. #clinicaltrials #clinicaldatamanagement #pharma

Let’s make #IBDVisible during this Crohn’s and Colitis awareness week. My colleague Marta Plana Ramón shared some interesting insights on the currently approved treatment options to manage Crohn’s disease and ulcerative colitis. Today, I wanted to continue that journey and show what is in the pipeline for inflammatory bowel disease (IBD) by quickly analyzing the number of ongoing and planned interventional, commercially-sponsored clinical trials within the IBD space. An analysis brought to you by Anju Software's clinical intelligence solution TA Scan 📊 #IBD #UlcerativeColitis #CrohnsDisease #DataScience #TAScan